Myovant Sciences Ltd.

NYSE: MYOV · Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM

Myovant Sciences Revenue

Myovant Sciences reported an annual revenue of $230.97M, reflecting a 289.39% growth. For the quarter ending December 31, 2022, Myovant Sciences generated $100.23M in revenue.
Revenue (ttm)
230.97M
Revenue Growth
289.39%
Price / Sales Ratio
5.36
Revenue / Employee
398.92K
Employees
579
Market Cap
2.62B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Mar 31, 2022 230.97M +289.39%
Mar 31, 2021 59.32M +Infinity%
Mar 31, 2020 0 n/a
Mar 31, 2019 0 n/a
Mar 31, 2018 0 n/a
Mar 31, 2017 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.